These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10561333)

  • 1. Gemcitabine is active in relapsed Hodgkin's disease.
    Lucas JB; Horwitz SM; Horning SJ; Sayegh A
    J Clin Oncol; 1999 Aug; 17(8):2627-8. PubMed ID: 10561333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controversial aspects in the current treatment of Hodgkin's disease].
    Vicente J
    Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
    [No Abstract]   [Full Text] [Related]  

  • 3. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 6. Masked Hodgkin's disease: the pruriginous disguise.
    Stefanato CM; Reyes-Mugica M
    Pediatr Hematol Oncol; 1996; 13(3):293-4. PubMed ID: 8735347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of recurrences of Hodgkin's disease in children].
    Armata J; Moryl-Bujakowska A
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1301-4. PubMed ID: 6201835
    [No Abstract]   [Full Text] [Related]  

  • 8. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 10. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternating drug combinations for advanced Hodgkin's disease.
    N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
    [No Abstract]   [Full Text] [Related]  

  • 12. MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
    Glick JH; Tsiatis A
    Ann Intern Med; 1986 Jun; 104(6):876-8. PubMed ID: 2422998
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment for localized Hodgkin's disease.
    Crowther D
    Hematol Oncol; 1984; 2(1):63-6. PubMed ID: 6203822
    [No Abstract]   [Full Text] [Related]  

  • 14. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

  • 15. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
    Longo DL
    Cancer Invest; 1996; 14(4):353-60. PubMed ID: 8689431
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of chemotherapy in the management of early stage Hodgkin's disease.
    Rosenberg SA
    Hematol Oncol; 1984; 2(1):61-3. PubMed ID: 6203821
    [No Abstract]   [Full Text] [Related]  

  • 17. ABVD chemotherapy in the treatment of Hodgkin's disease.
    Bonadonna G; Santoro A
    Cancer Treat Rev; 1982 Mar; 9(1):21-35. PubMed ID: 6175409
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of mediastinal involvement in early Hodgkin's disease.
    Zucali R; Zanini M; Banfi A
    Hematol Oncol; 1984; 2(1):72-4. PubMed ID: 6203823
    [No Abstract]   [Full Text] [Related]  

  • 19. Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
    Straus DJ; Gaynor J; Myers J; Merke D; Chapman D; Caravelli J; Nisce LZ; Lee BJ; Clarkson BD
    Recent Results Cancer Res; 1989; 117():191-6. PubMed ID: 2481329
    [No Abstract]   [Full Text] [Related]  

  • 20. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.